NA Sperm Separation Devices Market - Industry Trends and Forecast to 2029
North America sperm separation devices market is projected to register a substantial CAGR of 17.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.
Market Segmentation
North America Sperm Separation Devices Market, By Devices (Centrifugation Devices and Centrifugation-Free Devices), Media (Sperm Wash Media, Sperm Processing Media, Sperm Freezing Media, and Other Media), Assisted Devices (Imaging Systems, Incubators, Cabinets, and Others), Application (Fertility, Diagnostics, Forensics, and Others), Technology (On-chip, Electrophoresis, and Dielectrophoresis), End User (Hospitals, Clinics, Cryobanks, Surgical Centers, Research Institutes, Fertility Centers, IVF Laboratories, and Others) Distribution Channel (Direct Tender, Third Party Distributors, and Others), Countries (U.S., Mexico, and Canada), Industry Trends & Forecast to 2029
Some of the major factors contributing to the growth of the North America sperm separation devices market are:
• Increasing public awareness about the infertility
• Available treatment options will cushion the market’s growth rate
Market Players
Some of the key market players in the North America sperm separation devices market are listed below:
• Bonraybio Co., Ltd.
• DxNow
• Hamilton Thorne, Ltd.
• Promega Corporation
• Nidacon International AB
• Memphasys
• Menicon Co., Ltd.
• The Cooper Companies Inc.
• SAR Healthline Pvt Ltd.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook